UNASSIGNED: The aim of this study was to determine the short-term clinical and radiological outcomes of a new stemless TSA design.
UNASSIGNED: A prospective multicentre study including 154 total shoulder arthroplasty patients with a follow up of 12 months was performed. At the time of follow up 129 patients were available for review. The adjusted Constant Murley score,1 Oxford Shoulder Score, EQ-5D-5L score and radiographs were examined preoperatively, 3 and 12 months after the implantation of the new stemless TSA implant GLOBAL ICON™ (DePuy Synthes, Warsaw, IN, USA). Complications were documented.
UNASSIGNED: Implant Kaplan-Meier survivorship was 98.7% at 12 months. From baseline to 12 months follow-up, all scores showed a progressive significant mean improvement. The mean adjusted Constant score increased from 42.3 to 96.1 points (p<0.001). The Oxford Shoulder Score showed an increase of 21.6 points (p<0.001). The postoperative radiographs showed no continuous radiolucent lines, subsidence, aseptic loosening or progressive radiolucency, but one osteolytic lesion was observed. Only 2 prostheses were revised.
UNASSIGNED: The new GLOBAL ICON stemless TSA showed good clinical and radiographic results at short-term follow up which were comparable to early results of other stemless TSA. Further studies with longer follow up are needed in the future.
■本研究的目的是确定新的无茎TSA设计的短期临床和放射学结果。
■进行了一项前瞻性多中心研究,包括154例全肩关节置换术患者,随访12个月。在随访时,有129名患者可供检查。调整后的ConstantMurley得分,1牛津肩得分,术前检查EQ-5D-5L评分和X光片,植入新的无茎TSA植入物GLOBALICON™后3个月和12个月(DePuySynthes,华沙,IN,美国)。并发症已记录在案。
■植入物Kaplan-Meier在12个月时的生存率为98.7%。从基线到12个月的随访,所有评分均表现出渐进的显著平均改善.平均调整的Constant评分从42.3分增加到96.1分(p<0.001)。牛津肩评分增加21.6分(p<0.001)。术后X光片显示没有连续的射线可透线,沉降,无菌性松动或渐进性射线不透性,但观察到一个溶骨性病变。仅修改了2个假体。
■新的GLOBALICON无茎TSA在短期随访中显示出良好的临床和影像学结果,与其他无茎TSA的早期结果相当。未来需要进一步的研究和更长时间的随访。